{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:09:27Z","timestamp":1785802167872,"version":"3.56.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":959,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS111280"],"award-info":[{"award-number":["R01 NS111280"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003919","name":"Kleine-Levin Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003919","id-type":"DOI","asserted-by":"publisher"}]},{"name":"KLS-France"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s13311-020-00919-1","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T04:09:51Z","timestamp":1599710991000},"page":"20-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Idiopathic Hypersomnia and Other Hypersomnia Syndromes"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2329-6847","authenticated-orcid":false,"given":"Lynn Marie","family":"Trotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Arnulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-020-00919-1_bib1","doi-asserted-by":"crossref","unstructured":"Trotti LM. Waking up is the hardest thing I do all day: Sleep inertia and sleep drunkenness. Sleep Med Rev 2016.","DOI":"10.1016\/j.smrv.2016.08.005"},{"key":"10.1007\/s13311-020-00919-1_bib2","doi-asserted-by":"crossref","unstructured":"Maness C, Saini P, Bliwise DL, Olvera V, Rye DB, Trotti LM. Systemic exertion intolerance disease\/chronic fatigue syndrome is common in sleep centre patients with hypersomnolence: A retrospective pilot study. J Sleep Res 2018;e12689.","DOI":"10.1111\/jsr.12689"},{"key":"10.1007\/s13311-020-00919-1_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2869.2010.00824.x","article-title":"Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness","volume":"19","author":"Vernet","year":"2010","journal-title":"J Sleep Res"},{"key":"10.1007\/s13311-020-00919-1_bib4","doi-asserted-by":"crossref","unstructured":"Miglis MG, Schneider L, Kim P, Cheung J, Trotti LM. Frequency and Severity of Autonomic Symptoms in Idiopathic Hypersomnia. J Clin Sleep Med 2020.","DOI":"10.1016\/j.sleep.2019.11.713"},{"key":"10.1007\/s13311-020-00919-1_bib5","unstructured":"International classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine 2014."},{"key":"10.1007\/s13311-020-00919-1_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/sleep\/32.6.753","article-title":"Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients","volume":"32","author":"Vernet","year":"2009","journal-title":"Sleep"},{"key":"10.1007\/s13311-020-00919-1_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.25141","article-title":"Alternative diagnostic criteria for idiopathic hypersomnia: A 32-hour protocol","volume":"83","author":"Evangelista","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-020-00919-1_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2869.2012.01032.x","article-title":"Daytime continuous polysomnography predicts MSLT results in hypersomnias of central origin","volume":"22","author":"Pizza","year":"2013","journal-title":"J Sleep Res"},{"key":"10.1007\/s13311-020-00919-1_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/ana.23818","article-title":"Excessive sleep duration and quality of life","volume":"73","author":"Ohayon","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-020-00919-1_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004685","article-title":"Modulation of Vigilance in the Primary Hypersomnias by Endogenous Enhancement of GABAA Receptors","volume":"4","author":"Rye","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1007\/s13311-020-00919-1_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40675-019-00154-x","article-title":"Is Idiopathic Hypersomnia a Circadian Rhythm Disorder?","volume":"5","author":"Landzberg","year":"2019","journal-title":"Current Sleep Medicine Reports"},{"key":"10.1007\/s13311-020-00919-1_bib12","doi-asserted-by":"crossref","unstructured":"Boucetta S, Montplaisir J, Zadra A, et al. Altered Regional Cerebral Blood Flow in Idiopathic Hypersomnia. Sleep 2017;40.","DOI":"10.1093\/sleep\/zsx140"},{"key":"10.1007\/s13311-020-00919-1_bib13","doi-asserted-by":"crossref","unstructured":"Pomares FB, Boucetta S, Lachapelle F, et al. Beyond sleepy: structural and functional changes of the default-mode network in idiopathic hypersomnia. Sleep 2019.","DOI":"10.1093\/sleep\/zsz156"},{"key":"10.1007\/s13311-020-00919-1_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.sleep.2016.07.012","article-title":"Diurnal and nocturnal cardiovascular variability and heart rate arousal response in idiopathic hypersomnia","volume":"24","author":"Sforza","year":"2016","journal-title":"Sleep Med"},{"key":"10.1007\/s13311-020-00919-1_bib15","doi-asserted-by":"crossref","unstructured":"Fronczek R, Arnulf I, Baumann CR, Maski K, Pizza F, Trotti LM. To Split or to Lump? Classifying the Central Disorders of Hypersomnolence. Sleep 2020.","DOI":"10.1093\/sleep\/zsaa044"},{"key":"10.1007\/s13311-020-00919-1_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/acschemneuro.7b00374","article-title":"An Overview of the Clinical Uses, Pharmacology, and Safety of Modafinil","volume":"9","author":"Murillo-Rodriguez","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1007\/s13311-020-00919-1_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/jsr.12201","article-title":"Modafinil in the treatment of idiopathic hypersomnia without long sleep time-a randomized, double-blind, placebo-controlled study","volume":"24","author":"Mayer","year":"2015","journal-title":"J Sleep Res"},{"key":"10.1007\/s13311-020-00919-1_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.5665\/sleep.3480","article-title":"Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial","volume":"37","author":"Philip","year":"2014","journal-title":"Sleep"},{"key":"10.1007\/s13311-020-00919-1_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sleep.2018.02.009","article-title":"Maintenance of Wakefulness Test, real and simulated driving in patients with narcolepsy\/hypersomnia","volume":"55","author":"Sagaspe","year":"2019","journal-title":"Sleep Med"},{"key":"10.1007\/s13311-020-00919-1_bib20","doi-asserted-by":"crossref","first-page":"A250","DOI":"10.1093\/sleepj\/zsx050.676","article-title":"The effectiveness of modafinil for the treatment of idiopathic hypersomnia","volume":"40","author":"Inoue","year":"2017","journal-title":"Sleep"},{"key":"10.1007\/s13311-020-00919-1_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0278-5846(88)90014-0","article-title":"Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil","volume":"12","author":"Bastuji","year":"1988","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1007\/s13311-020-00919-1_bib22","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/sleep\/30.10.1274","article-title":"Idiopathic hypersomnia: a study of 77 cases","volume":"30","author":"Anderson","year":"2007","journal-title":"Sleep"},{"key":"10.1007\/s13311-020-00919-1_bib23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.5664\/jcsm.27658","article-title":"Idiopathic hypersomnia: clinical features and response to treatment","volume":"5","author":"Ali","year":"2009","journal-title":"J Clin Sleep Med"},{"key":"10.1007\/s13311-020-00919-1_bib24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.sleep.2011.03.010","article-title":"Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy","volume":"12","author":"Lavault","year":"2011","journal-title":"Sleep Med"},{"key":"10.1007\/s13311-020-00919-1_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1176\/jnp.17.3.405","article-title":"Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness","volume":"17","author":"Schwartz","year":"2005","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1007\/s13311-020-00919-1_bib26","unstructured":"Modafinil package insert. 2004; Available from: https:\/\/www.modafinil.com\/prescribe\/index.html."},{"key":"10.1007\/s13311-020-00919-1_bib27","unstructured":"Reymond D. Alertec (modafinil) and the risk of congenital anomalies. Government of Canada\/Health Canada; 2019 [10\/30\/2019]; Available from: https:\/\/www.healthycanadians.gc.ca\/recall-alert-rappel-avis\/hc-sc\/2019\/70201a-eng.php."},{"key":"10.1007\/s13311-020-00919-1_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jama.2019.20008","article-title":"First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations","volume":"323","author":"Damkier","year":"2020","journal-title":"JAMA"},{"key":"10.1007\/s13311-020-00919-1_bib29","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","article-title":"Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin","volume":"30","author":"Morgenthaler","year":"2007","journal-title":"Sleep"},{"key":"10.1007\/s13311-020-00919-1_bib30","unstructured":"Adderall package insert. 2007; Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/011522s040lbl.pdf."},{"key":"10.1007\/s13311-020-00919-1_bib31","unstructured":"Sunosi (solriamfetol) package insert. 2019; Available from: https:\/\/sunosihcp.com."},{"key":"10.1007\/s13311-020-00919-1_bib32","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1164\/rccm.201806-1100OC","article-title":"Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3): A Randomized Controlled Trial","volume":"199","author":"Schweitzer","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1007\/s13311-020-00919-1_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ana.25423","article-title":"A Randomized Study of Solriamfetol for Excessive Sleepiness in Narcolepsy","volume":"85","author":"Thorpy","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-020-00919-1_bib34","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.sleep.2014.01.021","article-title":"Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review","volume":"15","author":"Leu-Semenescu","year":"2014","journal-title":"Sleep Med"},{"key":"10.1007\/s13311-020-00919-1_bib35","doi-asserted-by":"crossref","first-page":"P3.6","DOI":"10.1212\/WNL.92.15_supplement.P3.6-035","article-title":"Hormonal Contraceptive and Pitolisant CYP3A4 Induction","volume":"92","author":"Robert","year":"2019","journal-title":"Neurology."},{"key":"10.1007\/s13311-020-00919-1_bib36","unstructured":"Wakix (pitolisant) package insert. 2019; Available from: https:\/\/wakix.com."},{"key":"10.1007\/s13311-020-00919-1_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1152\/jn.00134.2016","article-title":"Clarithromycin increases neuronal excitability in CA3 pyramidal neurons through a reduction in GABAergic signaling","volume":"117","author":"Bichler","year":"2017","journal-title":"J Neurophysiol"},{"key":"10.1007\/s13311-020-00919-1_bib38","unstructured":"Garcia PS, Jenkins A, editors. Inhibition of the GABA(A) receptor by a macrolide but not by a lincosamide antibiotic. Proceedings of the 2009 Annual Meeting of the American Society of Anesthesiologists 2009."},{"key":"10.1007\/s13311-020-00919-1_bib39","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ana.24459","article-title":"Clarithromycin in gamma-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial","volume":"78","author":"Trotti","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-020-00919-1_bib40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijcard.2015.01.020","article-title":"Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial","volume":"182","author":"Winkel","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1007\/s13311-020-00919-1_bib41","unstructured":"Clarithromycin Full Prescribing Information (package insert). Updated 1\/2019."},{"key":"10.1007\/s13311-020-00919-1_bib42","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.5664\/jcsm.6196","article-title":"Flumazenil for the Treatment of Refractory Hypersomnolence: Clinical Experience with 153 Patients","volume":"12","author":"Trotti","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"10.1007\/s13311-020-00919-1_bib43","doi-asserted-by":"crossref","unstructured":"Kelty E, Martyn V, O'Neil G, Hulse G. Use of subcutaneous flumazenil preparations for the treatment of idiopathic hypersomnia: A case report. J Psychopharmacol 2014.","DOI":"10.1177\/0269881114523865"},{"key":"10.1007\/s13311-020-00919-1_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.clinph.2011.05.024","article-title":"Differences in findings of nocturnal polysomnography and multiple sleep latency test between narcolepsy and idiopathic hypersomnia","volume":"123","author":"Takei","year":"2012","journal-title":"Clin Neurophysiol"},{"key":"10.1007\/s13311-020-00919-1_bib45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/smrv.2000.0098","article-title":"Sleep inertia","volume":"4","author":"Tassi","year":"2000","journal-title":"Sleep Med Rev"},{"key":"10.1007\/s13311-020-00919-1_bib46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.sleep.2015.10.005","article-title":"Benefits and risk of sodium oxybate in idiopathic hypersomnia versus narcolepsy type 1: a chart review","volume":"17","author":"Leu-Semenescu","year":"2016","journal-title":"Sleep Med"},{"key":"10.1007\/s13311-020-00919-1_bib47","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/sleep\/32.9.1229","article-title":"Narcolepsy with long sleep time: a specific entity?","volume":"32","author":"Vernet","year":"2009","journal-title":"Sleep"},{"key":"10.1007\/s13311-020-00919-1_bib48","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.5664\/jcsm.4042","article-title":"Psychomotor vigilance task demonstrates impaired vigilance in disorders with excessive daytime sleepiness","volume":"10","author":"Thomann","year":"2014","journal-title":"J Clin Sleep Med"},{"key":"10.1007\/s13311-020-00919-1_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.sleep.2018.09.021","article-title":"Disease-specific attention impairment in disorders of chronic excessive daytime sleepiness","volume":"53","author":"Ramm","year":"2018","journal-title":"Sleep Med"},{"key":"10.1007\/s13311-020-00919-1_bib50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.smrv.2005.01.001","article-title":"Excessive daytime sleepiness and parkinsonism","volume":"9","author":"Arnulf","year":"2005","journal-title":"Sleep Med Rev"},{"key":"10.1007\/s13311-020-00919-1_bib51","doi-asserted-by":"crossref","unstructured":"Ghergan A, Coupaye M, Leu-Semenescu S, et al. Prevalence and Phenotype of Sleep Disorders in 60 Adults With Prader-Willi Syndrome. Sleep 2017;40:https:\/\/doi.org\/10.1093\/sleep\/zsx162.","DOI":"10.1093\/sleep\/zsx162"},{"key":"10.1007\/s13311-020-00919-1_bib52","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1183\/09031936.00016808","article-title":"Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study","volume":"33","author":"P\u00e9pin","year":"2009","journal-title":"Eur Resp J"},{"key":"10.1007\/s13311-020-00919-1_bib53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1183\/09031936.00040410","article-title":"Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms","volume":"38","author":"Vernet","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1007\/s13311-020-00919-1_bib54","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/brain\/awu391","article-title":"Increased sleep need and daytime sleepiness 6 months after traumatic brain injury: a prospective controlled clinical trial","volume":"138","author":"Imbach","year":"2015","journal-title":"Brain"},{"key":"10.1007\/s13311-020-00919-1_bib55","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ana.24298","article-title":"Damage to histaminergic tuberomammillary neurons and other hypothalamic neurons with traumatic brain injury","volume":"77","author":"Valko","year":"2015","journal-title":"Annals of Neurology"},{"key":"10.1007\/s13311-020-00919-1_bib56","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/ajrccm.163.4.2005036","article-title":"Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea\/hypopnea syndrome","volume":"163","author":"Kingshott","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1007\/s13311-020-00919-1_bib57","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.clinthera.2006.05.013","article-title":"Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea\/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults","volume":"28","author":"Roth","year":"2006","journal-title":"Clinical Therapeutics"},{"key":"10.1007\/s13311-020-00919-1_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081802","article-title":"Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis","volume":"8","author":"Sheng","year":"2013","journal-title":"PLoS One"},{"key":"10.1007\/s13311-020-00919-1_bib59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s13311-013-0236-z","article-title":"Treatment of the sleep disorders associated with Parkinson's disease","volume":"11","author":"Trotti","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1007\/s13311-020-00919-1_bib60","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/jamaneurol.2017.3171","article-title":"Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial","volume":"75","author":"Buchele","year":"2018","journal-title":"JAMA Neurology"},{"key":"10.1007\/s13311-020-00919-1_bib61","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1212\/WNL.0b013e3181fd62a2","article-title":"Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury","volume":"75","author":"Kaiser","year":"2010","journal-title":"Neurology"},{"key":"10.1007\/s13311-020-00919-1_bib62","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.HTR.0000308721.77911.ea","article-title":"A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury","volume":"23","author":"Jha","year":"2008","journal-title":"J Head Trauma Rehabil"},{"key":"10.1007\/s13311-020-00919-1_bib63","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.5664\/jcsm.4196","article-title":"Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension","volume":"10","author":"Menn","year":"2014","journal-title":"J Clin Sleep Med"},{"key":"10.1007\/s13311-020-00919-1_bib64","doi-asserted-by":"crossref","unstructured":"Annane D, Moore DH, Barnes PR, Miller RG. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy. Cochrane Database Syst Rev 2006;CD003218.","DOI":"10.1002\/14651858.CD003218.pub2"},{"key":"10.1007\/s13311-020-00919-1_bib65","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.smrv.2016.01.004","article-title":"Sleep propensity in psychiatric hypersomnolence: A systematic review and meta-analysis of multiple sleep latency test findings","volume":"31","author":"Plante","year":"2017","journal-title":"Sleep Med Rev"},{"key":"10.1007\/s13311-020-00919-1_bib66","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00006842-200003000-00013","article-title":"Differences in nocturnal and daytime sleep between primary and psychiatric hypersomnia: diagnostic and treatment implications","volume":"62","author":"Vgontzas","year":"2000","journal-title":"Psychosom Med"},{"key":"10.1007\/s13311-020-00919-1_bib67","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/jsr.12498","article-title":"Objective measures of sleep duration and continuity in major depressive disorder with comorbid hypersomnolence: a primary investigation with contiguous systematic review and meta-analysis","volume":"26","author":"Plante","year":"2017","journal-title":"J Sleep Res"},{"key":"10.1007\/s13311-020-00919-1_bib68","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jad.2017.11.054","article-title":"Reduced resting-state thalamostriatal functional connectivity is associated with excessive daytime sleepiness in persons with and without depressive disorders","volume":"227","author":"Plante","year":"2018","journal-title":"J Affect Disord"},{"key":"10.1007\/s13311-020-00919-1_bib69","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/jcp.0b013e31815abefb","article-title":"Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study","volume":"27","author":"Dunlop","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1007\/s13311-020-00919-1_bib70","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4088\/JCP.v64n0911","article-title":"Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study","volume":"64","author":"DeBattista","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1007\/s13311-020-00919-1_bib71","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1474-4422(12)70187-4","article-title":"Diagnosis, disease course, and management of patients with Kleine-Levin syndrome","volume":"11","author":"Arnulf","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-020-00919-1_bib72","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/01.WNL.0000036605.89977.D0","article-title":"Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses","volume":"59","author":"Dauvilliers","year":"2002","journal-title":"Neurology"},{"key":"10.1007\/s13311-020-00919-1_bib73","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ana.21333","article-title":"Kleine-Levin syndrome: a systematic study of 108 patients","volume":"63","author":"Arnulf","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-020-00919-1_bib74","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5665\/sleep.1600","article-title":"Relationship between Kleine-Levin Syndrome and upper respiratory Infection in Taiwan","volume":"35","author":"Huang","year":"2012","journal-title":"Sleep"},{"key":"10.1007\/s13311-020-00919-1_bib75","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ana.24350","article-title":"Kleine-Levin syndrome in 120 patients: Differential diagnosis and long episodes","volume":"77","author":"Lavault","year":"2015","journal-title":"Annals of Neurology"},{"key":"10.1007\/s13311-020-00919-1_bib76","doi-asserted-by":"crossref","first-page":"855","DOI":"10.5665\/sleep.5642","article-title":"Cerebrospinal fluid orexin A levels and autonomic function in Kleine-Levin syndrome","volume":"39","author":"Wang","year":"2016","journal-title":"Sleep"},{"key":"10.1007\/s13311-020-00919-1_bib77","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/brain\/awu112","article-title":"Feeling unreal: a functional imaging study in 41 patients with Kleine-Levin syndrome","volume":"137","author":"Kas","year":"2014","journal-title":"Brain"},{"key":"10.1007\/s13311-020-00919-1_bib78","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1176\/ajp.147.7.951","article-title":"Autonomic events in Kleine-Levin syndrome","volume":"147","author":"Hegarty","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1007\/s13311-020-00919-1_bib79","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/brain\/awh620","article-title":"Kleine-Levin syndrome: a systematic review of 186 cases in the literature","volume":"128","author":"Arnulf","year":"2005","journal-title":"Brain"},{"key":"10.1007\/s13311-020-00919-1_bib80","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2869.2001.00272.x","article-title":"Clinical and polysomnographic characteristics of 34 patients with Kleine-Levin syndrome","volume":"10","author":"Gadoth","year":"2001","journal-title":"J Sleep Res"},{"key":"10.1007\/s13311-020-00919-1_bib81","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/01.wnl.0000304133.00875.2b","article-title":"Polysomnography in Kleine-Levin syndrome","volume":"70","author":"Huang","year":"2008","journal-title":"Neurology"},{"key":"10.1007\/s13311-020-00919-1_bib82","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-020-00919-1_bib83","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5665\/sleep.5458","article-title":"Long-term cognitive impairment in Kleine-Levin syndrome","volume":"39","author":"Uguccioni","year":"2015","journal-title":"Sleep"},{"key":"10.1007\/s13311-020-00919-1_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12690","article-title":"Emerging psychiatric disorders in Kleine-Levin syndrome","volume":"27","author":"Groos","year":"2018","journal-title":"J Sleep Res"},{"key":"10.1007\/s13311-020-00919-1_bib85","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/sleep\/28.8.955","article-title":"SPECT findings in the Kleine-Levin syndrome","volume":"28","author":"Huang","year":"2005","journal-title":"Sleep"},{"key":"10.1007\/s13311-020-00919-1_bib86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archneur.1982.00510130027005","article-title":"A pathologic basis for Kleine-Levin syndrome","volume":"39","author":"Carpenter","year":"1982","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-020-00919-1_bib87","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1212\/WNL.34.12.1597","article-title":"Increased cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in Kleine-Levin syndrome","volume":"34","author":"Koerber","year":"1984","journal-title":"Neurology"},{"key":"10.1007\/s13311-020-00919-1_bib88","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/070674377602100508","article-title":"Kleine-Levin syndrome in a female patient","volume":"21","author":"Takrani","year":"1976","journal-title":"Can Psychiatr Assoc J"},{"key":"10.1007\/s13311-020-00919-1_bib89","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-2008-1071559","article-title":"Clinical features of Kleine-Levin syndrome with localized encephalitis","volume":"24","author":"Fenzi","year":"1993","journal-title":"Neuropediatrics"},{"key":"10.1007\/s13311-020-00919-1_bib90","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.sleep.2015.02.540","article-title":"Serum cytokine levels in Kleine-Levin syndrome","volume":"16","author":"Kornum","year":"2015","journal-title":"Sleep Medicine"},{"key":"10.1007\/s13311-020-00919-1_bib91","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.sleep.2007.06.015","article-title":"Clinical characteristics and HLA typing of a family with Kleine-Levin syndrome","volume":"9","author":"Bahammam","year":"2008","journal-title":"Sleep medicine"},{"key":"10.1007\/s13311-020-00919-1_bib92","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.5665\/sleep.6014","article-title":"Familial Kleine-Levin syndrome","volume":"39","author":"Nguyen","year":"2016","journal-title":"Sleep"},{"key":"10.1007\/s13311-020-00919-1_bib93","doi-asserted-by":"crossref","unstructured":"Ambati A, Hillary R, Semenescu SL, Lin L, Ollila H, Farber N, Huang Y, Dauvilliers Y, KLS Working Group, Arnulf I, Mignot E. Strong Gene-Environment Interactions of Trank1 Gene Polymorphisms with Birth Difficulties in Kleine Levin Syndrome. Sleep, 2020;43(Suppl 1):A10-A11","DOI":"10.1093\/sleep\/zsaa056.025"},{"key":"10.1007\/s13311-020-00919-1_bib94","doi-asserted-by":"crossref","first-page":"e1488","DOI":"10.1212\/WNL.0000000000005349","article-title":"IV steroids during long episodes of Kleine-Levin syndrome","volume":"90","author":"Leotard","year":"2018","journal-title":"Neurology"},{"key":"10.1007\/s13311-020-00919-1_bib95","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.5664\/jcsm.3176","article-title":"Kleine-levin syndrome treated with clarithromycin","volume":"9","author":"Rezvanian","year":"2013","journal-title":"J Clin Sleep Med"},{"key":"10.1007\/s13311-020-00919-1_bib96","doi-asserted-by":"crossref","first-page":"457","DOI":"10.5664\/jcsm.3634","article-title":"Further Experience using Clarithromycin in Patients with Kleine-Levin Syndrome","volume":"10","author":"Trotti","year":"2014","journal-title":"J Clin Sleep Med"},{"key":"10.1007\/s13311-020-00919-1_bib97","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1212\/WNL.0000000000002104","article-title":"Lithium therapy in Kleine-Levin syndrome: an open-label, controlled study in 130 patients","volume":"85","author":"Leu-Semenescu","year":"2015","journal-title":"Neurology"},{"key":"10.1007\/s13311-020-00919-1_bib98","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/WNL.25.5.436","article-title":"A menstruation-linked periodic hypersomnia. Kleine-Levin syndrome or new clinical entity?","volume":"25","author":"Billiard","year":"1975","journal-title":"Neurology"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00919-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-020-00919-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923011765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923011765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00919-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:03:36Z","timestamp":1761807816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923011765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1878747923011765"],"URL":"https:\/\/doi.org\/10.1007\/s13311-020-00919-1","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Idiopathic Hypersomnia and Other Hypersomnia Syndromes","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-020-00919-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}